跳至主要内容
临床试验/JPRN-UMIN000011752
JPRN-UMIN000011752已完成未知

Prospective, randomized, open-label, clinical trial evaluating the effects of dipeptidyl peptidase-4 (DPP4) inhibitors on progression of atherosclerotic plaques and endothelial function in type 2 diabetic patients - Clinical trial evaluating the effects of dipeptidyl peptidase-4 (DPP4) inhibitors

ational Defense Medical College0 个研究点目标入组 66 人开始时间: 2013年9月14日最近更新:
适应症

试验速览

阶段
未知
状态
已完成
发起方
入组人数
66

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
20years-old 至 80years-old(—)
性别
All

入选标准

  • 未提供

排除标准

  • 1) Allergy against DPP4 inhibitors 2) Type 1 diabetes or patients with positive anti-islet antibodies 3) Secondary diabetes 4) Poor-controlled diabetes (HbA1c>10.0 %) 5) Under administration of DPP-4 inhibitors or GLP-1 agonists 6) History of stroke, acute coronary syndrome or any cardiovascular diseases needed for inpatient-treatments within 6 months 7) Either level of aspartate aminotransaminase or alanine aminotransferase exceeds three-fold of the normal limits 8) End stage renal disease 9) Symptomatic (NYHA III or IV) congestive heart failure 10) Malignancies or other diseases with poor prognosis 11) Pregnant 12) Subjects whose doctor in charge do not agree to join the trial

研究者

发起方
ational Defense Medical College

相似试验